Invests $1.1 billion in 6 months, against $3.7 billion in 20 years
Flights from Mumbai and Kerala will also have to transit through these routes due to restrictions
'And the top 10 per cent will grow because they have to serve the market.'
FMCG, durables, pharma firms say they remain unclear about transition gains and losses
The travel agents have demanded refunds for customers
Vistara Chief Executive Officer Phee Teik Yeoh is expected to meet the senior management of BA over the next few days to discuss the partnership.
Airlines tell Arindam Majumder and Aneesh Phadnis they are forced to look at expats due to a lack of commanders, a position that requires experience.
Together with Jet Airways we will have 61 flights to Amsterdam and Paris during the winter season. That also makes us the second largest airline group after Lufthansa, which has 67 weekly flights, and we are catching up to become the first, says KLM CEO Pieter Elbers.
Tata Communications has elected the private equity (PE) veteran as a successor to Subodh Bhargava.
He's betting big on small stores to help him reach 10 million households by FY21, report Abhineet Kumar and Raghavendra Kamath.
Travel companies Cox & Kings and Thomas Cook explore initiatives aimed at tapping the niche market of travel packages for kids and the disabled.
Over 1.3 million, or 49% of passengers flew to the US via airports in the Gulf in FY16
IndiGo which has close to 40 per cent market share, at present has 129 aircraft and operates 883 daily flights to 44 destinations. It also has around 400 aircraft on order.
To win back customers, operators are offering discounts and cash-back, and are absorbing service tax
In the past, Qatar Airways has repeatedly expressed a desire to invest in IndiGo, the country's largest domestic airline.
Travels to Gulf accounted for 40% of India's international air traffic in 2016.
The Essar Oil, Rosneft deal also helped Arpwood Capital, boutique investment bank, co-founded by Rajeev Gupta and Raj Kataria, to grab the second spot in the mergers and acquisitions league table.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
Aneesh Phadnis and Veena Mani find out what the manufacturers and the hospitals have to say.
Offers 12.60% in revenue share to Cidco, while only other bidder GMR offered 10.44%.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances